Lupin Partners With Biomm To Launch Pegfilgrastim Biosimilar In Brazil

Filing For The Neulasta Biosimilar Was Accepted By The US FDA In June

 
• By Chloe Kent
  
India and Brazil flags
Biomm will distribute Lupin's pegfilgrastim generic in Brazil • Source: Alamy
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products